UBS Group’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Buy |
+2,523
| New | +$10.3K | ﹤0.01% | 7529 |
|
|
2025
Q1 | – | Sell |
-40,208
| Closed | -$59.1K | – | 9127 |
|
|
2024
Q4 | $59.1K | Buy |
40,208
+40,087
| +33,130% | +$58.9K | ﹤0.01% | 5971 |
|
|
2024
Q3 | $207 | Sell |
121
-19,237
| -99% | -$32.9K | ﹤0.01% | 7850 |
|
|
2024
Q2 | $40.8K | Buy |
19,358
+19,051
| +6,206% | +$40.2K | ﹤0.01% | 5699 |
|
|
2024
Q1 | $672 | Buy |
307
+296
| +2,691% | +$648 | ﹤0.01% | 7249 |
|
|
2023
Q4 | $38 | Hold |
11
| – | – | ﹤0.01% | 7804 |
|
|
2023
Q3 | $16 | Hold |
11
| – | – | ﹤0.01% | 8012 |
|
|
2023
Q2 | $17 | Sell |
11
-226
| -95% | -$349 | ﹤0.01% | 7616 |
|
|
2023
Q1 | $254 | Sell |
237
-10,294
| -98% | -$11K | ﹤0.01% | 8016 |
|
|
2022
Q4 | $12.2K | Sell |
10,531
-1,343
| -11% | -$1.56K | ﹤0.01% | 7116 |
|
|
2022
Q3 | $11K | Buy |
11,874
+11,348
| +2,157% | +$10.5K | ﹤0.01% | 7211 |
|
|
2022
Q2 | $1K | Buy |
526
+515
| +4,682% | +$979 | ﹤0.01% | 8871 |
|
|
2022
Q1 | $0 | Hold |
11
| – | – | ﹤0.01% | 9450 |
|
|
2021
Q4 | $0 | Hold |
11
| – | – | ﹤0.01% | 9295 |
|
|
2021
Q3 | $0 | Sell |
11
-16
| -59% | – | ﹤0.01% | 8626 |
|
|
2021
Q2 | $0 | Sell |
27
-316
| -92% | – | ﹤0.01% | 8462 |
|
|
2021
Q1 | $2K | Buy |
343
+61
| +22% | +$356 | ﹤0.01% | 7586 |
|
|
2020
Q4 | $2K | Buy |
282
+271
| +2,464% | +$1.92K | ﹤0.01% | 7075 |
|
|
2020
Q3 | $0 | Sell |
11
-10
| -48% | – | ﹤0.01% | 7279 |
|
|
2020
Q2 | $0 | Sell |
21
-471
| -96% | – | ﹤0.01% | 7225 |
|
|
2020
Q1 | $3K | Sell |
492
-110
| -18% | -$671 | ﹤0.01% | 6578 |
|
|
2019
Q4 | $6K | Buy |
602
+581
| +2,767% | +$5.79K | ﹤0.01% | 6443 |
|
|
2019
Q3 | $0 | Buy |
+21
| New | – | ﹤0.01% | 7101 |
|